首页> 美国卫生研究院文献>Canadian Journal of Comparative Medicine >Development and analytical validation of an enzyme linked immunosorbent assay for the measurement of canine gastric lipase immunoreactivity in serum
【2h】

Development and analytical validation of an enzyme linked immunosorbent assay for the measurement of canine gastric lipase immunoreactivity in serum

机译:酶联免疫吸附法测定血清中犬胃脂肪酶免疫反应性的开发及分析验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to develop and analytically validate an enzyme linked immunosorbent assay (ELISA) for measurement of canine gastric lipase immunoreactivity (cGLI). A sandwich ELISA was developed using canine gastric lipase (cGL) purified from canine stomachs and polyclonal antibodies directed against cGL, raised in rabbits and purified by affinity chromatography. The assay was validated by determination of sensitivity, working range, linearity, accuracy, precision, reproducibility, and the upper limit of the control range by determining the 97.5th percentile of serum cGLI concentration in 74 healthy canines. Sensitivity and working range in serum were 200 ng/L and 200 to 39 160 ng/L, respectively. Observed to expected ratios for dilutional parallelism for 3 serum samples and 3 dilutions ranged from 86.1% to 244.2% (mean ± standard deviation [s]; 125.4% ± 48.2%). Observed to expected ratios for spiking recoveries for 3 serum samples and 6 spiking concentrations ranged from 66.4% to 152.5% (mean ± s; 104.5% ± 22.9%). Intra-assay and interassay variabilities for 3 different serum samples were 25.5%, 9.4%, and 13.4% and 26.0%, 17.2%, and 14.4%, respectively. The upper limit of the control range for serum cGLI was 662 ng/L. We concluded that the ELISA for cGLI described here is highly sensitive and shows a wide working range. However, the validation characteristics for this assay are suboptimal and below values of approximately 2.000 ng/L the assay is more semiquantitative in nature. Despite its limitations, whether this assay is useful for the diagnosis of canine gastric disorders remains to be determined.
机译:这项研究的目的是开发和分析验证用于测量犬胃脂肪酶免疫反应性(cGLI)的酶联免疫吸附测定(ELISA)。使用从犬胃中纯化的犬胃脂肪酶(cGL)和针对cGL的多克隆抗体(在兔中饲养并通过亲和色谱法纯化)开发了三明治式ELISA。通过确定74个健康犬的血清cGLI浓度的97.5个百分位数,通过测定灵敏度,工作范围,线性,准确性,精密度,可重复性和控制范围上限来验证该方法。血清的敏感性和工作范围分别为200 ng / L和200至39160 ng / L。观察到的3个血清样品和3个稀释液的稀释平行度的预期比率为86.1%至244.2%(平均值±标准偏差[s]; 125.4%±48.2%)。观察到的3种血清样品和6种加标浓度的加标回收率的预期比例为66.4%至152.5%(平均值±s; 104.5%±22.9%)。 3种不同血清样品的测定内和测定间变异性分别为25.5%,9.4%和13.4%,26.0%,17.2%和14.4%。血清cGLI的控制范围上限为662 ng / L。我们得出的结论是,此处描述的cGLI的ELISA具有很高的灵敏度,并且显示了很宽的工作范围。但是,该测定的验证特征不是最理想的,并且低于约2.000 ng / L的值时,该测定本质上是半定量的。尽管有其局限性,该测定是否可用于犬胃病的诊断尚待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号